However, ERα-E2 may also exert an antitumor effect as it is indicated by the activation of the expression of tumor suppressor miR-1271, which targets SNAI2 and suppresses the process of epithelial-mesenchymal transition (EMT) in breast cancer cells. Here, ESR1 is linked to breast cancer.